focus -WSS

focus

author：comprehensive 2025-09-27 10:04:57 - browse：82358

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Steward Health Care files for bankruptcy

WSS

Medicare says breakthrough device reimbursement rule to come by summer

It was time to plan for my old age. If only I could stop crying

Dairy farmers resist CDC push for PPE against bird flu virus

Study: AI not yet building 'n

Use wet bulb globe temperature, not heat index, to protect workers

After gene therapy, two congenitally deaf children hear for the first time

leisure time

focus

focus

Apple is now the first public company to be valued at $3 trillion

With heat waves through August, officials warn of health risks

Psychedelics group wrestles with new pharma identity

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Study: Adult vaccinations pay for themselves in societal benefits

Moonlake's readout produced a cash windfall. Risks remain

CDC wastewater surveillance dashboard to track bird flu hotspots

Alkermes shareholders re

Researchers on aging grapple with how to calculate biological age

Wikipedia

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Feed a cold, starve a fever? Here’s what science says

CDC wastewater surveillance dashboard to track bird flu hotspots

Making AI in medicine accessible to smaller, and rural hospitals

Failure, not just success, should guide future doctors

St. Louis police protesters begin picking up checks in $4.9 million settlement

knowledge

focus

explore

hotspot